Fifth Third Bancorp’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.5M Sell
39,993
-3,251
-8% -$1.21M 0.03% 361
2026
Q1
$12.7M Buy
43,244
+31,973
+284% +$10.5M 0.02% 401
2025
Q4
$3.95M Sell
11,271
-303
-3% -$102K 0.01% 348
2025
Q3
$3.74M Sell
11,574
-7,362
-39% -$2.29M 0.01% 352
2025
Q2
$7.37M Buy
18,936
+2,329
+14% +$937K 0.03% 275
2025
Q1
$7.22M Buy
16,607
+409
+3% +$164K 0.03% 267
2024
Q4
$5.98M Sell
16,198
-5,763
-26% -$2.41M 0.02% 290
2024
Q3
$11.4M Sell
21,961
-1,065
-5% -$569K 0.04% 228
2024
Q2
$12.5M Sell
23,026
-1,161
-5% -$614K 0.05% 220
2024
Q1
$12.5M Sell
24,187
-2,097
-8% -$1.04M 0.05% 222
2023
Q4
$12.4M Sell
26,284
-5,471
-17% -$2.53M 0.05% 217
2023
Q3
$13.8M Sell
31,755
-4,688
-13% -$2.13M 0.06% 196
2023
Q2
$16.2M Sell
36,443
-1,362
-4% -$628K 0.07% 194
2023
Q1
$17.4M Buy
37,805
+10,386
+38% +$4.94M 0.08% 190
2022
Q4
$14.1M Buy
27,419
+4,161
+18% +$2.11M 0.07% 214
2022
Q3
$10.6M Buy
23,258
+2,027
+10% +$970K 0.06% 232
2022
Q2
$10.2M Buy
21,231
+2,184
+11% +$1.08M 0.05% 245
2022
Q1
$9.36M Buy
19,047
+516
+3% +$236K 0.04% 270
2021
Q4
$8.59M Buy
18,531
+800
+5% +$337K 0.03% 286
2021
Q3
$6.61M Buy
17,731
+1,490
+9% +$566K 0.03% 310
2021
Q2
$6.2M Buy
16,241
+1,013
+7% +$387K 0.03% 318
2021
Q1
$5.47M Sell
15,228
-3,590
-19% -$1.15M 0.03% 330
2020
Q4
$6.04M Sell
18,818
-3,991
-17% -$1.22M 0.03% 301
2020
Q3
$6.13M Buy
22,809
+1,735
+8% +$467K 0.03% 289
2020
Q2
$5.54M Buy
21,074
+1,814
+9% +$484K 0.03% 303
2020
Q1
$4.37M Buy
19,260
+1,416
+8% +$386K 0.03% 292
2019
Q4
$5.39M Buy
17,844
+2,190
+14% +$603K 0.03% 300
2019
Q3
$3.76M Buy
15,654
+375
+2% +$103K 0.02% 329
2019
Q2
$4.31M Buy
15,279
+1,267
+9% +$346K 0.03% 313
2019
Q1
$4.02M Buy
14,012
+131
+0.9% +$37.9K 0.03% 303
2018
Q4
$3.65M Sell
13,881
-78
-0.6% -$21.4K 0.03% 298
2018
Q3
$3.83M Sell
13,959
-240
-2% -$62.3K 0.02% 306
2018
Q2
$3.38M Sell
14,199
-158
-1% -$36.6K 0.02% 319
2018
Q1
$3.15M Buy
14,357
+150
+1% +$35.2K 0.02% 328
2017
Q4
$3.2M Sell
14,207
-1,969
-12% -$419K 0.02% 330
2017
Q3
$3.07M Sell
16,176
-499
-3% -$95K 0.02% 329
2017
Q2
$3.14M Sell
16,675
-392
-2% -$70.4K 0.02% 333
2017
Q1
$2.82M Sell
17,067
-1,269
-7% -$202K 0.02% 351
2016
Q4
$2.64M Sell
18,336
-775
-4% -$104K 0.02% 365
2016
Q3
$2.4M Sell
19,111
-1,928
-9% -$249K 0.02% 372
2016
Q2
$2.76M Sell
21,039
-2,427
-10% -$332K 0.02% 355
2016
Q1
$3.26M Sell
23,466
-4,205
-15% -$562K 0.03% 333
2015
Q4
$3.86M Buy
27,671
+2,416
+10% +$333K 0.03% 306
2015
Q3
$3.54M Sell
25,255
-415
-2% -$62.4K 0.03% 317
2015
Q2
$4.21M Sell
25,670
-564
-2% -$90.1K 0.04% 296
2015
Q1
$4.05M Sell
26,234
-4,139
-14% -$589K 0.04% 318
2014
Q4
$3.82M Sell
30,373
-13,202
-30% -$1.63M 0.03% 336
2014
Q3
$5.21M Buy
43,575
+6,125
+16% +$703K 0.05% 286
2014
Q2
$4.03M Sell
37,450
-315
-0.8% -$32.5K 0.04% 328
2014
Q1
$3.76M Sell
37,765
-2,928
-7% -$265K 0.04% 335
2013
Q4
$3.76M Sell
40,693
-4,935
-11% -$438K 0.04% 330
2013
Q3
$3.81M Sell
45,628
-2,109
-4% -$181K 0.04% 330
2013
Q2
$3.91M Buy
+47,737
New +$3.57M 0.04% 312

Other funds holding ELV

Fifth Third Bancorp's ELV Position: Q2 2026 in Review

Fifth Third Bancorp reduced its Elevance Health (ELV) stake by 7.5% in Q2 2026, selling an estimated $1.21M and leaving 39,993 shares worth $15.5M. The position accounts for 0.03% of the portfolio, ranked #361.

Fifth Third Bancorp first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. The position peaked at $17.4M in Q1 2023. 1,602 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Fifth Third Bancorp held 39,993 shares of Elevance Health worth $15.5M as of Q2 2026.
  • Fifth Third Bancorp sold 3,251 Elevance Health shares in Q2 2026, an estimated $1.21M.
  • Elevance Health made up 0.03% of Fifth Third Bancorp's portfolio in Q2 2026, its #361 holding.
  • Fifth Third Bancorp first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
  • Fifth Third Bancorp's Elevance Health position peaked at $17.4M in Q1 2023.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.